ENvue Medical Completes Move Of NanoVibronix Manufacturing From Israel To The U.S. And Consolidates R&D Operations In Tel Aviv To Lower Opex And Improve Cost Structure
By completing this transition, the Company now manufactures its entire NanoVibronix line in the United States, leveraging these U.S.-based operations to establish a stronger foundation for long-term growth and strategic
ENvue Medical moved where it makes its NanoVibronix products from Israel to the U.S., and combined some offices to spend less money. This shows the company is trying to run more efficiently and set up for growing bigger later.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.